Brief: Conmed Q4 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.2
05/02/2025 21:05
Feb 05 (Reuters) - Conmed Q4 EPS USD 1.08. * Q4 income from operations USD 52.499 million vs. IBES estimate USD 57.5 million * Q4 net income USD 33.754 million * Q4 sales USD 345.944 million vs. IBES estimate USD 341 million * Q4 pretax profit USD 43.642 million vs. IBES estimate USD 48.2 million * outlook FY adjusted EPS USD 4.25-4.4
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED